共 50 条
Final three-year follow-up analysis of phase I/II study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma
被引:0
|作者:
Asai, Katsunori
Narita, Yoshitaka
Nagane, Motoo
Mishima, Kazuhiko
Terui, Yasuhito
Arakawa, Yoshiki
Yonezawa, Hajime
Fukuhara, Noriko
Sugiyama, Kazuhiko
Shinojima, Naoki
Aoi, Arata
Nishikawa, Ryo
机构:
[1] Osaka Int Canc Inst, Dept Neurosurg, Osaka, Japan
[2] Natl Canc Ctr, Dept Neurosurg & Neurooncol, Tokyo, Japan
[3] Kyorin Univ, Fac Med, Dept Neurosurg, Tokyo, Japan
[4] Saitama Med Univ Int Med Ctr, Dept Neurooncol Neurosurg, Saitama, Japan
[5] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Hematol Oncol, Tokyo, Japan
[6] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan
[7] Kagoshima Univ Hosp, Dept Neurosurg, Kagoshima, Japan
[8] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan
[9] Hiroshima Univ Hosp, Dept Clin Oncol, Hiroshima, Japan
[10] Hiroshima Univ Hosp, Neurooncol Program, Hiroshima, Japan
[11] Kumamoto Univ Hosp, Dept Neurosurg, Kumamoto, Japan
[12] Ono Pharmaceut Co LTD, Dept Clin Dev, Osaka, Japan
关键词:
D O I:
暂无
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
7548
引用
收藏
页数:1
相关论文